MACC1 and cervical carcinoma: In univariate analysis, cervical cancer patients with AG/GG in MACC1 SNP rs975263 had 5 years survival rate 0.89 (95% CI=0.79-0.99) as compared to those with AA 0.79 (95% CI=0.70-0.88) with no significantly different 5 years survival rate (p=0.195, HR=0.49, 95% CI=0.16-1.45; Table 4).